Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR604 in Patients With Von Willebrand Disease
NCT07640893Phase 2Recruiting
- Sponsor
- Shanghai RAAS
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SR604 in von Willebrand disease (VWD), sponsored by Shanghai RAAS. Started Nov 2025; status: recruiting.
02
Drugs
SR604
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT07640893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640893.